Clinical trial
Neurotropin Treatment of Fibromyalgia
NCT00366535 · National Institute of Nursing Research (NINR), NIH · Completed
Key facts
| NCT number | NCT00366535 |
|---|---|
| Title | Neurotropin Treatment of Fibromyalgia |
| Official title | Neurotropin Treatment of Fibromyalgia |
| Lead sponsor | National Institute of Nursing Research (NINR), NIH |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH National Institutes of Health Clinical Center (CC) University of Michigan National Cancer Institute (NCI) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fibromyalgia |
| Intervention type | Drug |
| Interventions | Placebo, Neurotropin |
| Enrollment | 56 |
| Start date | Aug 1, 2006 |
| Primary completion | Dec 1, 2015 |
| Completion | Dec 1, 2015 |
| First posted | Aug 21, 2006 |
| Last update posted | Jun 27, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: